In Bacterial infections Afdiclave Dry Syrup is a medicine that helps to kill the bacteria that cause infections. This combination medicine can be used to treat many different bacterial infections. It causes loss of the useful bacteria that are present naturally in our body. It contains probiotics that help restore the useful bacteria, improve digestion and enhance overall health. Afdiclave Dry Syrup usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is not known whether it is safe to consume alcohol with Afdiclave Dry Syrup. Please consult your doctor.
Information regarding the use of Afdiclave Dry Syrup during pregnancy is not available. Please consult your doctor.
Afdiclave Dry Syrup is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Afdiclave Dry Syrup may cause side effects which could affect your ability to drive. Afdiclave Dry Syrup may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
Afdiclave Dry Syrup should be used with caution in patients with kidney disease. Dose adjustment of Afdiclave Dry Syrup may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Afdiclave Dry Syrup should be used with caution in patients with liver disease. Dose adjustment of Afdiclave Dry Syrup may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
If you miss a dose of Afdiclave Dry Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Total Healthcare || ₹14.5/tablet (25% cheaper)